Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_60